Anxiety and depressive disorders in college youth

Pediatric Clinics of North America

Volumn 52, Issue 1, 2005, Pages 97-134

  Bhave, Swati ^a   Nagpal, Jitendra ^b  

^a BOMBAY HOSPITAL   (India)

^b Vidyasagar Institute of Mental Health and Neurosciences Hospital   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ALPRAZOLAM; AMFEBUTAMONE; ANTIDEPRESSANT AGENT; BENZODIAZEPINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BUSPIRONE; CHLORDIAZEPOXIDE; CLOMIPRAMINE; CLONAZEPAM; CLORAZEPATE DIPOTASSIUM; DESIPRAMINE; DIAZEPAM; DOXEPIN; FLUMAZENIL; FLUOXETINE; FLURAZEPAM; IMIPRAMINE; LORAZEPAM; MONOAMINE OXIDASE INHIBITOR; OXAZEPAM; PAROXETINE; PROPRANOLOL; PROTRIPTYLINE; QUAZEPAM; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRAZODONE; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG; VENLAFAXINE;

AGGRESSION; AGORAPHOBIA; AKATHISIA; ANGER; ANOREXIA NERVOSA; ANORGASMIA; ANTEROGRADE AMNESIA; ANTICHOLINERGIC EFFECT; ANXIETY; ANXIETY DISORDER; APATHY; ATTENTION DEFICIT DISORDER; AVOIDANCE BEHAVIOR; BEHAVIOR DISORDER; BEHAVIOR THERAPY; BIPOLAR DEPRESSION; BODY DYSMORPHIC DISORDER; BODY WEIGHT DISORDER; BRAIN HEMORRHAGE; BULIMIA; COGNITIVE THERAPY; COLLEGE STUDENT; COMORBIDITY; CONSTIPATION; DEPRESSION; DIABETIC NEPHROPATHY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DIAPHORESIS; DIARRHEA; DISEASE CLASSIFICATION; DIZZINESS; DROWSINESS; DRUG APPROVAL; DRUG DEPENDENCE; DRUG EFFICACY; DRUG ERUPTION; DRUG HALF LIFE; DRUG HYPERSENSITIVITY; DRUG METABOLISM; DRUG OVERDOSE; DRUG SAFETY; DRUG TOLERABILITY; DYSTHYMIA; EJACULATION DISORDER; EMOTION; ENURESIS; ERECTILE DYSFUNCTION; EXTRAPYRAMIDAL SYMPTOM; FEAR; FLU LIKE SYNDROME; FLUSHING; GASTROINTESTINAL SYMPTOM; GENERALIZED ANXIETY DISORDER; GUILT; HEADACHE; HEART ARRHYTHMIA; HEART MUSCLE CONDUCTION DISTURBANCE; HELPLESSNESS; HUMAN; HUMAN RELATION; HYPERHIDROSIS; HYPERPYREXIA; HYPERTENSION; HYPERTHERMIA; INSOMNIA; INTERPERSONAL COMMUNICATION; KIDNEY FAILURE; LETHARGY; LIBIDO DISORDER; MAJOR DEPRESSION; MALAISE; MEMORY DISORDER; MENTAL CONCENTRATION; MENTAL DISEASE; MIGRAINE; MUSCLE CRAMP; MUSCLE DISEASE; MYALGIA; MYOCLONUS; NAUSEA; NERVOUSNESS; NIGHTMARE; OBSESSIVE COMPULSIVE DISORDER; ORTHOSTATIC HYPOTENSION; PANIC; PARESTHESIA; PEPTIC ULCER; PERCEPTION DISORDER; PHOBIA; POSTTRAUMATIC STRESS DISORDER; PSYCHOSIS; PSYCHOTHERAPY; RESTLESSNESS; REVIEW; RHABDOMYOLYSIS; RISK FACTOR; SEDATION; SEIZURE; SELF CONTROL; SELF ESTEEM; SEPARATION ANXIETY; SEROTONIN SYNDROME; SIDE EFFECT; SLEEP APNEA SYNDROME; SLEEP DISORDER; SOCIAL ADAPTATION; SOCIAL PHOBIA; SOMNOLENCE; STOMACH PAIN; SUICIDE; SUSTAINED DRUG RELEASE; SWEATING; TACHYCARDIA; TARDIVE DYSKINESIA; THORAX PAIN; TINNITUS; TREMOR; URINARY HESITANCY; URINE RETENTION; VERTIGO; VISUAL IMPAIRMENT; VIVID DREAM; WEIGHT GAIN; WEIGHT REDUCTION; WITHDRAWAL SYNDROME; XEROSTOMIA;

EID: 14844312897     PISSN: 00313955     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pcl.2004.11.004     Document Type: Review

References (93)

1. X. Parmelee Dean, and B. David Ronald Child and adolescent psychiatry. Mosby's neurology psychiatry access series 1996 Mosby St. Louis
2. T. Roth, and T.A. Roehrs Issues in the use of benzodiazepine therapy J Clin Psychiatry 53 1992 14 18
3. I. Lucki, K. Rickels, and A.M. Geller Chronic use of benzodiazepines and psychomotor and cognitive test performance Psychopharmacology (Berl) 88 1986 426 433
4. American Psychiatric Association Benzodiazepine dependence, toxicity and abuse: a task force report of the American Psychiatric Association 1990 American Psychiatric Association Washington (DC)
5. E.M. Sellers, J.F. Schneiderman, and M.K. Romach Comparative drug effects and abuse liability of lorazepam, buspirone, and secobarbital in nondependent subjects J Clin Psychopharmacol 12 1992 79 85
6. U. Busto, E.M. Sellers, and C.A. Naranjo Withdrawal reactions after long-term therapeutic use of benzodiazepines N Engl J Med 315 1986 854 857
7. J. Schopf Withdrawal phenomena after long-term administration of benzodiazepines: a review of recent investigations Pharmacopsychiatrie Neuro- Psychopharmakologie 16 1983 1 8
8. P.J. Tyrer, R. Own, and S. Dawling Gradual withdrawal of diazepam after long-term therapy Lancet 1 1983 1402 1406
9. H. Ashton Protracted withdrawal syndromes from benzodiazepines J Subst Abuse Treat 8 1991 19 28
10. R. Noyes Jr, M.J. Gravey, and B.L. Cook Benzodiazepine withdrawal: a review of evidence J Clin Psychiatry 49 1988 382 389
11. R.B. Zipursky, R.W. Baker, and B. Zimmer Alprazolam withdrawal delirium unresponsive to diazepam: case report J Clin Psychiatry 46 1985 344 345
12. L.B. Marangell, M.J. Silver, and D.C. Gauff Pharmacology and electro convulsive therapy Textbook of clinical psychiatry 2003 American Psychiatric Publishing Washington, DC
13. J. Dixon, S.J. Power, and E.M. Grundy Sedation for local anaesthesia: comparison of intravenous midazolam and diazepam Anaesthesia 39 1984 372 378
14. J.A. Reitan, W. Porter, and M. Braunstein Comparison of psychomotor skills and amnesia after induction of anesthesia with midazolam or thiopental Anesth Analg 65 1986 933 937
15. S.R. Votey, G.M. Bosse, and M.J. Bayer Flumazenil: a new benzodiazepine antagonist Ann Emerg Med 20 1991 181 188
16. J. Cohn, and C.S. Wilcox Low-sedation potential of buspirone compared with alprazolam and lorazepam in the treatment of anxious patients: a double-blind study J Clin Psychiatry 47 1986 409 412
17. H.L. Goldberg, and R.J. Finnerty The comparative efficacy of buspirone and diazepam in the treatment of anxiety Am J Psychiatry 136 1979 1184 1187
18. D.V. Sheehan, A.B. Raj, and K.H. Sheehan Is buspirone effective for panic disorder? J Clin Psychopharmacol 10 1990 3 11
19. D.R. Gastfried, and J.F. Rosenbaum Adjunctive buspirone in benzodiazepine treatment of four patients with panic disorder Am J Psychiatry 146 1989 914 916
20. K.V. Harvey, and R. Balon Augmentation with buspirone: a review Ann Clin Psychiatry 7 1995 143 147
21. L.K. Laird Issues in the monopharmacotherapy and polypharmacotherapy of obsessive-compulsive disorder Psychopharmacol Bull 32 1996 569 578
22. D.J. Munjack, J. Bruns, and P.L. Baltazar A pilot study of buspirone in the treatment o social phobia J Anxiety Disorder 5 1991 87 98
23. F.R. Schneier, J.B. Saoud, and R.C. Campeas Buspirone in social phobia J Clin Psychopharmacol 13 1992 251 256
24. R.E. Rakel Long-term buspirone therapy for chronic anxiety: a multicenter international study to determine safety South Med J 83 1990 194 198
25. H. Moskowitz, and A. Smiley Effects of chronically administered buspirone and diazepam on driving-related skills and performance J Clin Psychiatry 43 1982 45 55
26. J.O. Cole, M.G. Orzak, and B. Beake Assessment of the abuse liability of buspirone in recreational sedative users J Clin Psychiatry 43 1982 69 74
27. D.J. Greenblatt, R.I. Shader, and D.R. Abernethy Drug therapy: current status of benzodiazepines N Engl J Med 309 1983 410 416
28. K. Rickels, W.G. Case, and R.W. Downing Long-term diazepam therapy and clinical outcome JAMA 250 1983 767 771
29. R. Hoehn-Saric, D.R. McLeod, and W.D. Zimmerli Differential effects of alprazolam and imipramine in generalized anxiety disorder: somatic vs psychic symptoms J Clin Psychiatry 49 1988 293 301
30. R.J. Kahn, D. Menair, and R.S. Lipman Imipramine and chlordiazepoxide in depressive and anxiety disorders: efficacy in anxious outpatients Arch Gen Psychiatry 43 1986 79 85
31. M.B. Keller, and D.L. Hanks Anxiety symptom relief in depression treatment outcomes J Clin Psychiatry 56 1995 22 29
32. S.A. Spier, G.E. Tesar, and J.F. Rosenbaum Treatment of panic disorder and agoraphobia with clonazepam J Clin Psychiatry 47 1986 238 242
33. G.E. Tesar High-potency benzodiazepines for short-term management of panic disorder: the US evidence J Clin Psychiatry 15 1990 4 10
34. D.F. Klein, D.C. Ross, and P. Cohen Panic and avoidance in agoraphobia; application of path analysis of treatment studies Arch Gen Psychiatry 44 1987 377 385
35. C.M. Zitrin, D.F. Klein, and M.G. Woerner Treatment of phobias: comparison of imipramine and placebo Arch Gen Psychiatry 40 1983 125 138
36. D.V. Sheehan, J. Ballenger, and G. Jacobsen Treatment of endogenous anxiety with phobic, hysterical, and hypochondrial symptoms Arch Gen Psychiatry 39 1980 51 59
37. I.M. van Vlient, H.G. Westenberg, and J.A. Den Boer MAO inhibitors in panic disorder: clinical effects of treatment with brofaromine: a double blind-blind placebo controlled study Psychopharmacology (Berl) 112 1993 483 489
38. J.A. den Boer, I.M. van Vliet, and H.G. Westenberg Recent developments in the psychopharmacology of social phobia Eur Arch Psychiatry Clin Neurosci 244 1995 309 316
39. S. Oehrberg, P.E. Christiansen, and K. Behnke Paroxetine in the treatment of panic disorder: a randomized, double-blind, placebo-controlled study Br J Psychiatry 167 1995 374 379
40. F.R. Schenier, M.R. Liebowitz, and S.O. Davies Fluoxetine in panic disorder J Clin Psychopharmacol 10 1990 119 121
41. H.G.M. Westenberg, and J.A. den Boer Clinical and biochemical effects of selective serotonin-uptake inhibitors in anxiety disorders M. Gastpar J.S. Wakelin Selective serotonin reuptake inhibitors: novel or commonplace agents? 1988 S KIarger Basel (Switzerland) 84 99
42. B. Black, T.W. Uhde, and M.E. Tancer Fluoxetine for the treatment of social phobia [letter] J Clin Psychopharmacol 12 1992 293 295
43. M. Van Ameringen, C. Mancini, and D.L. Streiner Fluoxetine efficacy in social phobia J Clin Psychiatry 54 1993 27 32
44. H.G. Westernberg, and J.A. den Boer New findings in the treatment of panic disorder Pharmacopsychiatry 26 1993 30 33
45. M.A. Liebowitz, J.M. Gorman, and A.J. Fyer Pharmacotherapy of social phobia: an interim report of a placebo-controlled comparison of phenelzine and atenolol J Clin Psychiatry 49 1988 252 257
46. R.D. Marshall, F.R. Schneier, and B.A. Fallon Medication therapy for social phobia J Clin Psychiatry 55 1994 33 37
47. J.R.T. Davidson, S.M. Fort, and R.D. Smith Long-term treatment of social phobia with clonazepam J Clin Psychiatry 52 1991 16 20
48. C.S. Gelernter, T.W. Uhde, and P. Climbolic Cognitive-behavioural and pharmacologic treatment for social phobia: a preliminary study Arch Gen Psychiatry 48 1991 938 945
49. J.W. Jefferson Social phobia: a pharmacologic treatment overview J Clin Psychiatry 56 1995 18 24
50. P.J. Drew, J.N. Barnes, and S.J. Evans The effect of acute beta-adrenoceptor blockade on examination performance Br J Clin Pharmacol 19 1985 783 786
51. L.R. Hertely, S. Unagapen, and I. Davie The effect of beta-adrenergic blocking drugs on speakers' performance and memory Br J Psychiatry 142 1983 512 517
52. C.O. Brantigan, T.A. Brantigan, and N. Joseph Effect of beta blockade and beta stimulation on stage fright Am J Med 72 1982 88 94
53. S.C. Yudofsky, and J.M. Silver Beta-blockers in the treatment of performance anxiety Harvard Mental Health Letter 4 1987 8
54. Clomipramine Collaborative Study Group Clomipramine in the treatment of patients with obsessive-compulsive disorder Arch Gen Psychiatry 48 1991 730 738
55. C.P. Freeman, M.R. Trimble, and J.F. Deakin Fluvoxamine versus clomipramine in the treatment of obsessive-compulsive disorder: a multi-center, randomized, double-blind parallel group J Clin Psychiatry 55 1994 301 305
56. W.K. Goodman, L.H. Price, and P.L. Delgado Specificity of serotonin reuptake inhibitors in the treatment of obsessive-compulsive disorder: comparison of luvoxamine and desipramine Arch Gen Psychiatry 47 1990 577 585
57. W.K. Goodman, M.J. Kozak, and M. Liebowitz Treatment of obsessive- compulsive disorder with fluvoxamine: a multi-centre, double-blind, placebo-controlled trial Int Clin Psychopharmacol 11 1996 21 29
58. T.L. Perse, J.H. Greist, and J.W. Jefferson Fluvoxamine treatment of obsessive-compulsive disorder Am J Psychiatry 144 1988 1543 1548
59. E. Mundo, S.R. Bareggi, and R. Pirola Long-term pharmacotherapy of obsessive-compulsive disorder: a double-blind controlled study J Clin Psychopharmacol 17 1997 4 10
60. American Psychiatric Association Diagnostic and statistical manual of mental disorders 4th edition 1994 American Psychiatric Association Washington (DC)
61. J.A. Liberman, and A. Tasman Antidepressant medication Psychiatrist drugs 2000 WB Saunders Company Philadelphia 53 56
62. H.C. Everett The use of bethanechol chloride with tricyclic antidepressants Am J Psychiatry 132 1976 1202 1204
63. J. Yager Bethanecol chloride can reverse erectile and ejaculatory dysfunction induced by tricyclic antidepressants and mazindol: case report J Clin Psychiatry 47 1986 210 211
64. A.H. Glassman The newer antidepressant drugs and their cardiovascular effects Psychopharmacol Bull 20 1984 272 279
65. M.H. Fernstrom, R.L. Krowinksi, and D.J. Kupfer Chronic imipramine treatment weight gain Psychiatry Res 17 1986 269 273
66. D.J. Kupfer, P.A. Coble, and M.S. Rubinstein Changes in weight during treatment for depression Psychosom Med 41 1979 535 544
67. G.P. Wedin, G.M. Oderda, and W Klein-Schwartz Relative toxicity of cyclic antidepressants Ann Emerg Med 15 1986 797 804
68. J.W. Daily, and D.K. Naritoku Antidepressants and seizures: clinical anecdotes overshadow neuroscience Biochem Pharmacol 52 1996 1323 1329
69. D.L. Rosenstein, J.C. Nelson, and S.C. Jacobs Seizures associated with antidepressants: a review J Clin Psychiatry 54 1993 289 299
70. G.D. Gammon, and C. Hansen A case of akinesia induced by amoxapine Am J Psychiatry 141 1984 283 284
71. D.R. Ross, J.I. Walker, and J. Paterson Akathisia induced by amoxapine Am J Psychiatry 140 1983 115 116
72. J.E. Thornton, and S.M. Stahl Case report of tardive dyskinesia and parkinsonism associated with amoxapine therapy Am J Psychiatry 141 1984 704 705
73. M.J. Doughty, and W.M. Lyle Medications used to prevent migraine headaches and their potential ocular adverse effects Optom Vis Sci 72 1995 879 891
74. J.A. Hamilton, and U. Halbreich Special aspects of neuropsychiatric illness I women: with a focus on depression Annu Rev Med 44 1993 355 364
75. V. Manna, F. Bolino, and L. Di Cicco Chronic tension-type headache, mood depression and serotonin: therapeutic effects of fluvoxamine and mianserine Headache 34 1994 44 49
76. F.M. Jacobsen Low-dose trazodone as a hypnotic in patients treated with MAOIs and other psychotropics: a pilot study J Clin Psychiatry 51 1990 298 302
77. A.A. Nierenberg, and P.E. Keck Jr Management of monoamine oxidase inhibitor-associated insomnia with trazodone J Clin Psychopharmacol 9 1989 42 45
78. C.D. Bouwer, and B.H. Harvey Phasic craving for carbohydrate observed with citalopram Int Clin Psychopharmacol 11 1996 273 278
79. S. Fisher, T.A. Kent, and S.G. Bryant Postmarketing surveillance by patient self-monitoring: preliminary data for sertraline versus fluoxetine J Clin Psychiatry 56 1995 288 296
80. A. Metz, and R.I. Shader Adverse interactions encountered when using trazodone to treat insomnia associated with fluoxetine Int Clin Psychopharmacol 5 1990 191 194
81. L.B. Marangell, M.J. Silver, and D.C. Gauff Pharmacology and electro convulsive therapy R.E. Hales S.C. Yudofsky Textbook of clinical psychiatry 4th edition 2003 American Psychiatric Publishing Washington, DC 1057 1059
82. B. Francois, P. Marquet, and J. Roustan Serotonin syndrome due to an overdose of moclobemide and clomipramine: a potentially life-threatening association Intensive Care Med 23 1997 122 124
83. M.J. Hodgman, T.G. Martin, and E.P. Krenzelok Serotonin syndrome due to venlafaxine and maintenance tranylcypromine therapy Hum Exp Toxicol 16 1997 14 17
84. P. Kolecki Venlafaxine induced serotonin syndrome occurring after abstinence from phenelzine for more than two weeks [letter] J Toxicol Clin Toxicol 35 1997 211 212
85. C.M. Beasley Jr, D.N. Masica, and J.H. Heiligenstein Possible monoamine oxidase inhibitor-serotonin uptake inhibitor interaction: fluoxetine clinical data and preclinical findings J Clin Psychopharmacol 13 1993 312 320
86. L.B. Marangell, M.J. Silver, and D.C. Gauff Pharmacology and electro convulsive therapy R.E. Hales S.C. Yudofsky Textbook of clinical psychiatry 4th edition 2003 American Psychiatric Publishing Washington, DC 1059 1061
87. M.R. Liebowitz, F.M. Quitkin, and J.W. Steward Phenelzine vs imipramine in atypical depression: a preliminary report Arch Gen Psychiatry 41 1984 669 677
88. F. Qitkin, A. Rifkin, and D.F. Klein Monoamine oxidase inhibitors: a review of antidepressant effectiveness Arch Gen Psychiatry 35 1979 749 760
89. C.L. Ravaris, D.S. Robinson, and J.O. Ives Phenelzine and amitriptyline in the treatment of depression: a comparison of present and past studies Arch Gen Psychiatry 37 1980 1075 1080
90. S. Zisook A clinical overview of monoamine oxidase inhibitors Psychosomatics 26 1985 240 246
91. J. Amsterdam, and N.J. Berwish High-dose tranylcypromine therapy for refractory depression Pharmacopsychiatry 22 1989 21 25
92. C.C. Weise, M.K. Stein, and J. Pereira-Ogan Amitriptyline once daily versus three times daily in depressed outpatients Arch Gen Psychiatry 37 1980 555 560
93. N.J. Coupland, C.J. Bell, and J.P. Potokar Serotonin reuptake inhibitor withdrawal J Clin Psychopharmacol 16 1996 356 362